Loading…
A rare adverse effect of montelukast treatment: ecchymosis
Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after startin...
Saved in:
Published in: | Respiratory care 2013-09, Vol.58 (9), p.e104-e106 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3488-fa5176e68502c404096d1388f18b0c79b963679396b8fbd967b4d5773119e0b43 |
---|---|
cites | |
container_end_page | e106 |
container_issue | 9 |
container_start_page | e104 |
container_title | Respiratory care |
container_volume | 58 |
creator | Aypak, Cenk Türedi, Özlem Solmaz, Nisa Yıkılkan, Hülya Görpelioğlu, Süleyman |
description | Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients montelukast should be discontinued. |
doi_str_mv | 10.4187/respcare.02298 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1428773660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A344393219</galeid><sourcerecordid>A344393219</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3488-fa5176e68502c404096d1388f18b0c79b963679396b8fbd967b4d5773119e0b43</originalsourceid><addsrcrecordid>eNptkctLxDAQh4Mouj6uHqUgiJeueTVNvC2LL1jwoueQphO32jZrkgr-93Z1FQWZwzDD9w0MP4SOCZ5yIsuLAHFlTYApplTJLTQhirOciYJvownGFOeEUb6H9mN8HkfBC7WL9ihjlEpZTtDlLAujnpn6DUKEDJwDmzLvss73CdrhxcSUpQAmddCnywysXb53PjbxEO0400Y42vQD9Hh99TC_zRf3N3fz2SK3jEuZO1OQUoCQBaaWY46VqAmT0hFZYVuqSgkmSsWUqKSraiXKitdFWTJCFOCKswN0_nV3FfzrADHprokW2tb04IeoCadyxIXAI3r6hT6ZFnTTO5-CsWtczxjnTDFK1EhN_6HGqqFrrO_BNeP-j3D2S1iCadMy-nZIje_jv5dt8DEGcHoVms6Ed02wXuelv_PSn3mNwsnmt6HqoP7BvwNiH-X4jkI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1428773660</pqid></control><display><type>article</type><title>A rare adverse effect of montelukast treatment: ecchymosis</title><source>PubMed Central</source><creator>Aypak, Cenk ; Türedi, Özlem ; Solmaz, Nisa ; Yıkılkan, Hülya ; Görpelioğlu, Süleyman</creator><creatorcontrib>Aypak, Cenk ; Türedi, Özlem ; Solmaz, Nisa ; Yıkılkan, Hülya ; Görpelioğlu, Süleyman</creatorcontrib><description>Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients montelukast should be discontinued.</description><identifier>ISSN: 0020-1324</identifier><identifier>EISSN: 1943-3654</identifier><identifier>DOI: 10.4187/respcare.02298</identifier><identifier>PMID: 23322887</identifier><language>eng</language><publisher>United States: Daedalus Enterprises, Inc</publisher><subject>Acetates - administration & dosage ; Acetates - adverse effects ; Adult ; Adverse and side effects ; Anti-inflammatory drugs ; Asthma ; Complications and side effects ; Drug therapy ; Drugs ; Ecchymosis - chemically induced ; Female ; Humans ; Leukotriene Antagonists - administration & dosage ; Leukotriene Antagonists - adverse effects ; Lower Extremity ; Montelukast ; Patient outcomes ; Quinolines - administration & dosage ; Quinolines - adverse effects ; Rhinitis, Allergic, Seasonal - drug therapy</subject><ispartof>Respiratory care, 2013-09, Vol.58 (9), p.e104-e106</ispartof><rights>COPYRIGHT 2013 Daedalus Enterprises, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3488-fa5176e68502c404096d1388f18b0c79b963679396b8fbd967b4d5773119e0b43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23322887$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aypak, Cenk</creatorcontrib><creatorcontrib>Türedi, Özlem</creatorcontrib><creatorcontrib>Solmaz, Nisa</creatorcontrib><creatorcontrib>Yıkılkan, Hülya</creatorcontrib><creatorcontrib>Görpelioğlu, Süleyman</creatorcontrib><title>A rare adverse effect of montelukast treatment: ecchymosis</title><title>Respiratory care</title><addtitle>Respir Care</addtitle><description>Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients montelukast should be discontinued.</description><subject>Acetates - administration & dosage</subject><subject>Acetates - adverse effects</subject><subject>Adult</subject><subject>Adverse and side effects</subject><subject>Anti-inflammatory drugs</subject><subject>Asthma</subject><subject>Complications and side effects</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Ecchymosis - chemically induced</subject><subject>Female</subject><subject>Humans</subject><subject>Leukotriene Antagonists - administration & dosage</subject><subject>Leukotriene Antagonists - adverse effects</subject><subject>Lower Extremity</subject><subject>Montelukast</subject><subject>Patient outcomes</subject><subject>Quinolines - administration & dosage</subject><subject>Quinolines - adverse effects</subject><subject>Rhinitis, Allergic, Seasonal - drug therapy</subject><issn>0020-1324</issn><issn>1943-3654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNptkctLxDAQh4Mouj6uHqUgiJeueTVNvC2LL1jwoueQphO32jZrkgr-93Z1FQWZwzDD9w0MP4SOCZ5yIsuLAHFlTYApplTJLTQhirOciYJvownGFOeEUb6H9mN8HkfBC7WL9ihjlEpZTtDlLAujnpn6DUKEDJwDmzLvss73CdrhxcSUpQAmddCnywysXb53PjbxEO0400Y42vQD9Hh99TC_zRf3N3fz2SK3jEuZO1OQUoCQBaaWY46VqAmT0hFZYVuqSgkmSsWUqKSraiXKitdFWTJCFOCKswN0_nV3FfzrADHprokW2tb04IeoCadyxIXAI3r6hT6ZFnTTO5-CsWtczxjnTDFK1EhN_6HGqqFrrO_BNeP-j3D2S1iCadMy-nZIje_jv5dt8DEGcHoVms6Ed02wXuelv_PSn3mNwsnmt6HqoP7BvwNiH-X4jkI</recordid><startdate>201309</startdate><enddate>201309</enddate><creator>Aypak, Cenk</creator><creator>Türedi, Özlem</creator><creator>Solmaz, Nisa</creator><creator>Yıkılkan, Hülya</creator><creator>Görpelioğlu, Süleyman</creator><general>Daedalus Enterprises, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201309</creationdate><title>A rare adverse effect of montelukast treatment: ecchymosis</title><author>Aypak, Cenk ; Türedi, Özlem ; Solmaz, Nisa ; Yıkılkan, Hülya ; Görpelioğlu, Süleyman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3488-fa5176e68502c404096d1388f18b0c79b963679396b8fbd967b4d5773119e0b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acetates - administration & dosage</topic><topic>Acetates - adverse effects</topic><topic>Adult</topic><topic>Adverse and side effects</topic><topic>Anti-inflammatory drugs</topic><topic>Asthma</topic><topic>Complications and side effects</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Ecchymosis - chemically induced</topic><topic>Female</topic><topic>Humans</topic><topic>Leukotriene Antagonists - administration & dosage</topic><topic>Leukotriene Antagonists - adverse effects</topic><topic>Lower Extremity</topic><topic>Montelukast</topic><topic>Patient outcomes</topic><topic>Quinolines - administration & dosage</topic><topic>Quinolines - adverse effects</topic><topic>Rhinitis, Allergic, Seasonal - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aypak, Cenk</creatorcontrib><creatorcontrib>Türedi, Özlem</creatorcontrib><creatorcontrib>Solmaz, Nisa</creatorcontrib><creatorcontrib>Yıkılkan, Hülya</creatorcontrib><creatorcontrib>Görpelioğlu, Süleyman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aypak, Cenk</au><au>Türedi, Özlem</au><au>Solmaz, Nisa</au><au>Yıkılkan, Hülya</au><au>Görpelioğlu, Süleyman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A rare adverse effect of montelukast treatment: ecchymosis</atitle><jtitle>Respiratory care</jtitle><addtitle>Respir Care</addtitle><date>2013-09</date><risdate>2013</risdate><volume>58</volume><issue>9</issue><spage>e104</spage><epage>e106</epage><pages>e104-e106</pages><issn>0020-1324</issn><eissn>1943-3654</eissn><abstract>Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients montelukast should be discontinued.</abstract><cop>United States</cop><pub>Daedalus Enterprises, Inc</pub><pmid>23322887</pmid><doi>10.4187/respcare.02298</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-1324 |
ispartof | Respiratory care, 2013-09, Vol.58 (9), p.e104-e106 |
issn | 0020-1324 1943-3654 |
language | eng |
recordid | cdi_proquest_miscellaneous_1428773660 |
source | PubMed Central |
subjects | Acetates - administration & dosage Acetates - adverse effects Adult Adverse and side effects Anti-inflammatory drugs Asthma Complications and side effects Drug therapy Drugs Ecchymosis - chemically induced Female Humans Leukotriene Antagonists - administration & dosage Leukotriene Antagonists - adverse effects Lower Extremity Montelukast Patient outcomes Quinolines - administration & dosage Quinolines - adverse effects Rhinitis, Allergic, Seasonal - drug therapy |
title | A rare adverse effect of montelukast treatment: ecchymosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A21%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20rare%20adverse%20effect%20of%20montelukast%20treatment:%20ecchymosis&rft.jtitle=Respiratory%20care&rft.au=Aypak,%20Cenk&rft.date=2013-09&rft.volume=58&rft.issue=9&rft.spage=e104&rft.epage=e106&rft.pages=e104-e106&rft.issn=0020-1324&rft.eissn=1943-3654&rft_id=info:doi/10.4187/respcare.02298&rft_dat=%3Cgale_proqu%3EA344393219%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3488-fa5176e68502c404096d1388f18b0c79b963679396b8fbd967b4d5773119e0b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1428773660&rft_id=info:pmid/23322887&rft_galeid=A344393219&rfr_iscdi=true |